BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38570181)

  • 1. Two-phase mechanism in the treatment of corneal stromal fibrosis with topical losartan.
    Wilson SE
    Exp Eye Res; 2024 May; 242():109884. PubMed ID: 38570181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits.
    Sampaio LP; Hilgert GSL; Shiju TM; Murillo SE; Santhiago MR; Wilson SE
    Exp Eye Res; 2022 Mar; 216():108940. PubMed ID: 35074340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The corneal fibrosis response to epithelial-stromal injury.
    Torricelli AA; Santhanam A; Wu J; Singh V; Wilson SE
    Exp Eye Res; 2016 Jan; 142():110-8. PubMed ID: 26675407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial basement membrane injury and regeneration modulates corneal fibrosis after pseudomonas corneal ulcers in rabbits.
    Marino GK; Santhiago MR; Santhanam A; Lassance L; Thangavadivel S; Medeiros CS; Bose K; Tam KP; Wilson SE
    Exp Eye Res; 2017 Aug; 161():101-105. PubMed ID: 28506643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFβ1 and TGFβ2 proteins in corneas with and without stromal fibrosis: Delayed regeneration of apical epithelial growth factor barrier and the epithelial basement membrane in corneas with stromal fibrosis.
    de Oliveira RC; Tye G; Sampaio LP; Shiju TM; DeDreu J; Menko AS; Santhiago MR; Wilson SE
    Exp Eye Res; 2021 Jan; 202():108325. PubMed ID: 33263285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal epithelial basement membrane: Structure, function and regeneration.
    Wilson SE; Torricelli AAM; Marino GK
    Exp Eye Res; 2020 May; 194():108002. PubMed ID: 32179076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial Basement Membrane Regeneration After PRK-Induced Epithelial-Stromal Injury in Rabbits: Fibrotic Versus Non-fibrotic Corneal Healing.
    de Oliveira RC; Sampaio LP; Shiju TM; Santhiago MR; Wilson SE
    J Refract Surg; 2022 Jan; 38(1):50-60. PubMed ID: 35020537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Losartan and Corticosteroid Additively Inhibit Corneal Stromal Myofibroblast Generation and Scarring Fibrosis After Alkali Burn Injury.
    Sampaio LP; Hilgert GSL; Shiju TM; Santhiago MR; Wilson SE
    Transl Vis Sci Technol; 2022 Jul; 11(7):9. PubMed ID: 35819289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Corneal Basement Membranes and Stromal Fibrosis.
    Medeiros CS; Marino GK; Santhiago MR; Wilson SE
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4044-4053. PubMed ID: 30098200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of epithelial basement membrane components nidogens and perlecan in corneal stromal cells in vitro.
    Santhanam A; Torricelli AA; Wu J; Marino GK; Wilson SE
    Mol Vis; 2015; 21():1318-27. PubMed ID: 26788024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta-3 localization in the corneal response to epithelial-stromal injury and effects on corneal fibroblast transition to myofibroblasts.
    Shiju TM; Sampaio LP; Martinez VV; Hilgert GSL; Wilson SE
    Exp Eye Res; 2023 Oct; 235():109631. PubMed ID: 37633325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblastic and bone marrow-derived cellularity in the corneal stroma.
    Wilson SE; Sampaio LP; Shiju TM; Carlos de Oliveira R
    Exp Eye Res; 2021 Jan; 202():108303. PubMed ID: 33068626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders.
    Wilson SE
    J Ocul Pharmacol Ther; 2023 Apr; 39(3):191-206. PubMed ID: 36877777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective perlecan-associated basement membrane regeneration and altered modulation of transforming growth factor beta in corneal fibrosis.
    Wilson SE
    Cell Mol Life Sci; 2022 Feb; 79(3):144. PubMed ID: 35188596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descemet's membrane injury and regeneration, and posterior corneal fibrosis, in rabbits.
    Sampaio LP; Shiju TM; Hilgert GSL; de Oliveira RC; DeDreu J; Menko AS; Santhiago MR; Wilson SE
    Exp Eye Res; 2021 Dec; 213():108803. PubMed ID: 34736886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1 and TGF-β Modulation of Epithelial Basement Membrane Components Perlecan and Nidogen Production by Corneal Stromal Cells.
    Saikia P; Thangavadivel S; Medeiros CS; Lassance L; de Oliveira RC; Wilson SE
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5589-5598. PubMed ID: 30480706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholine decreases formation of myofibroblasts and excessive extracellular matrix production in an in vitro human corneal fibrosis model.
    Słoniecka M; Danielson P
    J Cell Mol Med; 2020 Apr; 24(8):4850-4862. PubMed ID: 32176460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan Inhibition of Myofibroblast Generation and Late Haze (Scarring Fibrosis) After PRK in Rabbits.
    Sampaio LP; Hilgert GSL; Shiju TM; Santhiago MR; Wilson SE
    J Refract Surg; 2022 Dec; 38(12):820-829. PubMed ID: 36476304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB mediates the survival of corneal myofibroblast induced by angiotensin II.
    Pan HW; Cui YH; Zeng JW
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4220-8. PubMed ID: 24917146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Blast-Simulating Irregular PTK in Rabbits.
    Sampaio LP; Villabona-Martinez V; Shiju TM; Santhiago MR; Wilson SE
    Transl Vis Sci Technol; 2023 Sep; 12(9):20. PubMed ID: 37750746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.